AR021502A1 - Uso de derivados de azabicicloalcanos n-sustituidos para el tratamiento de enfermedades del sistema central nervioso - Google Patents

Uso de derivados de azabicicloalcanos n-sustituidos para el tratamiento de enfermedades del sistema central nervioso

Info

Publication number
AR021502A1
AR021502A1 ARP990105979A ARP990105979A AR021502A1 AR 021502 A1 AR021502 A1 AR 021502A1 AR P990105979 A ARP990105979 A AR P990105979A AR P990105979 A ARP990105979 A AR P990105979A AR 021502 A1 AR021502 A1 AR 021502A1
Authority
AR
Argentina
Prior art keywords
treatment
substituted
derivatives
azabicicloalcan
central system
Prior art date
Application number
ARP990105979A
Other languages
English (en)
Spanish (es)
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of AR021502A1 publication Critical patent/AR021502A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
ARP990105979A 1998-11-24 1999-11-24 Uso de derivados de azabicicloalcanos n-sustituidos para el tratamiento de enfermedades del sistema central nervioso AR021502A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19854147A DE19854147A1 (de) 1998-11-24 1998-11-24 Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht

Publications (1)

Publication Number Publication Date
AR021502A1 true AR021502A1 (es) 2002-07-24

Family

ID=7888824

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990105979A AR021502A1 (es) 1998-11-24 1999-11-24 Uso de derivados de azabicicloalcanos n-sustituidos para el tratamiento de enfermedades del sistema central nervioso

Country Status (21)

Country Link
EP (1) EP1133293A1 (no)
JP (1) JP2002530333A (no)
KR (1) KR20010080535A (no)
CN (1) CN1328455A (no)
AR (1) AR021502A1 (no)
AU (1) AU1775300A (no)
BG (1) BG105549A (no)
BR (1) BR9915589A (no)
CA (1) CA2352526A1 (no)
CZ (1) CZ20011796A3 (no)
DE (1) DE19854147A1 (no)
HK (1) HK1040933A1 (no)
HR (1) HRP20010472A2 (no)
HU (1) HUP0104416A3 (no)
IL (1) IL143181A0 (no)
NO (1) NO20012538L (no)
PL (1) PL348758A1 (no)
SK (1) SK7112001A3 (no)
TR (1) TR200101476T2 (no)
WO (1) WO2000030639A1 (no)
ZA (1) ZA200103976B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1836183A2 (en) 2004-12-13 2007-09-26 Galileo Pharmaceuticals, Inc. Spiro derivatives as lipoxygenase inhibitors
GB0812310D0 (en) 2008-07-03 2008-08-13 Syngenta Ltd Novel herbicides
WO2014111837A1 (en) * 2013-01-15 2014-07-24 Novartis Ag Use of alpha 7 nicotinic acetylcholine receptor agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004311A1 (en) * 1987-11-12 1989-05-18 American Home Products Corporation Polycyclicamines with psychotropic activity
DE4427648A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
DE4427647A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
WO2000030639A1 (de) 2000-06-02
AU1775300A (en) 2000-06-13
CZ20011796A3 (cs) 2002-05-15
ZA200103976B (en) 2002-05-16
DE19854147A1 (de) 2000-05-25
BR9915589A (pt) 2001-08-07
HK1040933A1 (zh) 2002-06-28
JP2002530333A (ja) 2002-09-17
PL348758A1 (en) 2002-06-03
HUP0104416A2 (hu) 2002-04-29
SK7112001A3 (en) 2001-12-03
BG105549A (en) 2001-12-29
EP1133293A1 (de) 2001-09-19
IL143181A0 (en) 2002-04-21
HUP0104416A3 (en) 2002-11-28
NO20012538D0 (no) 2001-05-23
KR20010080535A (ko) 2001-08-22
TR200101476T2 (tr) 2001-10-22
HRP20010472A2 (en) 2003-04-30
CA2352526A1 (en) 2000-06-02
CN1328455A (zh) 2001-12-26
NO20012538L (no) 2001-07-04

Similar Documents

Publication Publication Date Title
DE69232334D1 (de) Substituierte 3-aminochinuclidine
NO931635D0 (no) Fremgangsmaate for fremstilling av kinazolin-derivater
EA200200208A1 (ru) Синергитическая композиция
ES2191192T3 (es) Tienopirimidinas.
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
CY1108339T1 (el) Παραγωγα spiro(2h-1-benzopyran-2,4´-piperidine) ως αναστολεις της μεταφορας γλυκινης
BR0316296A (pt) Compostos lapacone e seus métodos de uso
AR028705A1 (es) Bis-arilsulfonas
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
HN1999000146A (es) Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
ES2101858T3 (es) Derivados de geneserina como inhibidores de colinesterasa.
ES2084996T3 (es) Piperazinas sustituidas utiles como agentes para el sistema nervioso central.
ES2063202T3 (es) Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
ATE236134T1 (de) Isoquinolinamin und phtalazinamin derivate, die reagieren mit crf rezeptoren
ES2196069T3 (es) Derivados morfinoides condensados con heterociclos.
DK0775143T3 (da) 3-substituerede 3H-2,3-benzodiazepinderivater, deres fremstilling og anvendelse som lægdemidler
PT916670E (pt) Pirrolo-(3,2-b) piridinas e o seu uso como agonistas do 5-ht1f
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
AR021502A1 (es) Uso de derivados de azabicicloalcanos n-sustituidos para el tratamiento de enfermedades del sistema central nervioso